Status:
RECRUITING
Attention Modulation of Local and Global Inhibition Mechanisms
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Optical Phenomena
Eligibility:
All Genders
8-75 years
Phase:
NA
Brief Summary
Human behavior is both flexible and adapted to the environmental context through inhibition capabilities; the investigator control the subject's behavior by repressing inappropriate responses and sele...
Eligibility Criteria
Inclusion
- All patients and healthy subjects:
- male and female, age from 18 to 75 years included
- normal vision or corrected vision
- covered by social security
- signed written informed consent
Exclusion
- unable to comply with requirements of the study (neurological, psychiatric, sensory or motor troubles)
- adults under legal protection
- Patient with hemispatial neglect:
- Inclusion Criteria:
- After a stroke (\> 1 month ago), presence of a neurological impairment documented by brain imaging (standard of care) and by clinical symptoms.
- The diagnosis will be dissociated from hemianopia by perimetry. The hemispatial neglect consists of a lack of perception and responsiveness concerning the controlesional visual hemifield.
- Patient with optic ataxia:
- After a stroke (\> 1 month ago), presence of neurological injury in parietal cortex only, supported by a standard of care cerebral MRI
- Present optic ataxia symptoms (The OA consists of pointing errors with the hand contralateral to the lesion (hand effect) and / or to visual targets presented in the field contralateral to the lesion (field effect)).
- Patient (adult and children) with attention-deficit hyperactivity disorder:
- present a diagnosis of ADHD subtype inattention or impulse / hyperactivity as established by a neuropsychologist.
- Children will be between 8 and 18 years old
- Adults will be between 18 and 75 years old.
- Participants will not report any comorbid learning disabilities to ADHD.
- For minors:
- \- Having obtained the written consent of the legal representative(s)
- Healthy subjects
- Inclusion Criteria:
- \- no known neurological injury
Key Trial Info
Start Date :
November 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 26 2031
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04279158
Start Date
November 26 2022
End Date
November 26 2031
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Recherche en Neuroscience de Lyon
Bron, France, 69500